收藏切换
Efficacy analysis of tenofovir alafenamide combined with mycophenolate mofetil in the treatment of hepatitis B-related Immunoglobulin A nephropathy
收藏切换
Li JIANG1, Mei XIE2, *, Xudong QIAO3
World Clinical Drug | 2022, 43(7) : 863 - 867
Less
收藏切换
World Clinical Drug | 2022, 43(7): 863-867
• Article •
Efficacy analysis of tenofovir alafenamide combined with mycophenolate mofetil in the treatment of hepatitis B-related Immunoglobulin A nephropathy
Full
Li JIANG1, Mei XIE2, *, Xudong QIAO3
Affiliations
  • 1.Yan'an Vocational and Technical College Faculty of Medicine, Yan'an 716099, Shaanxi Province, China
  • 2.Department of Infections Dseases Yan'an People's Hospital, Yan'an 716099, Shaanxi Province, China
  • 3.Department of Ultrasound Medicine, Xi'an Ninth Hospital, Xi'an 710054, Shaanxi Province, China
Published: 2022-07-10 doi: 10.13683/j.wph.2022.07.009
Outline
收藏切换
Objective

To investigate the efficacy of tenofovir alafenamide combined with mycophenolate mofetil in the treatment of hepatitis B-related immunoglobulin (Ig) A nephropathy.

Methods

A total of 82 patients with hepatitis B-related IgA nephropathy admitted to our hospital from February 2016 to February 2020 were included for retrospective analysis of their medical records, and 41 patients treated with tenofovir alafenamide were set as controls group, 41 patients treated with tenofovir alafenamide combined with mycophenolate mofetil were set as the study group. The clinical efficacy between the two groups were compared. The liver and kidney function and serum marker levels of hepatitis B virus (HBV) in the two groups before and after treatment were compared.

Results

The total effective rate in the study group was 95.12%, which was significantly higher than 78.05% in the control group (P<0.05). After treatment, the 24-hour urinary protein quantification (24-UCFP) and alanine aminotransferase (ALT) in the two groups were significantly lower than those before treatment (P<0.05), and albumin (Alb) was significantly higher than that before treatment (P<0.05). After treatment, 24-UCFP and ALT in the study group were significantly lower than those in the control group (P<0.05), and Alb was significantly higher than that in the control group (P<0.05). After treatment, the negative rate of HBV-DNA positive in the study group was significantly higher than that in the control group (P<0.05).

Conclusion

Tenofovir alafenamide combined with mycophenolate mofetil in the treatment of hepatitis B-related IgA nephropathy has a definite clinical effect, and has high application value for the improvement of liver and kidney function and the control of HBV.

tenofovir alafenamide  /  liver and kidney function  /  mycophenolate mofetil  /  immunoglobulin A nephropathy  /  hepatitis B virus
姜丽, 谢梅, 乔旭东. 丙酚替诺福韦联合吗替麦考酚酯治疗乙型肝炎相关性免疫球蛋白A肾病的疗效分析. 世界临床药物, 2022 , 43 (7) : 863 -867 . DOI: 10.13683/j.wph.2022.07.009
Li JIANG, Mei XIE, Xudong QIAO. Efficacy analysis of tenofovir alafenamide combined with mycophenolate mofetil in the treatment of hepatitis B-related Immunoglobulin A nephropathy[J]. World Clinical Drug, 2022 , 43 (7) : 863 -867 . DOI: 10.13683/j.wph.2022.07.009
Year 2022 volume 43 Issue 7
11
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.07.009
  • Receive Date:2022-03-09
  • Online Date:2026-11-19
  • Published:2022-07-10
Article Data
Affiliations
History
  • Received:2022-03-09
Affiliations
    1.Yan'an Vocational and Technical College Faculty of Medicine, Yan'an 716099, Shaanxi Province, China
    2.Department of Infections Dseases Yan'an People's Hospital, Yan'an 716099, Shaanxi Province, China
    3.Department of Ultrasound Medicine, Xi'an Ninth Hospital, Xi'an 710054, Shaanxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.07.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT